ipamorelin clinical trials humans (10mg vials) ipamorelin human clinical trials CJC-1295

Some patients use it for periods of high cognitive demand

However, this extrapolation from one organ to another is questionable as the exposure levels, the phase I metabolic capacity to generate NAPQI, the phase II metabolic capacity to eliminate APAP, and potential adaptive mechanisms in response to an APAP-induced cellular stress are not well described in the CNS system

Australia 218 , 426431 (2023)

This suggests that reduced inflammation through ketone utilization could provide the necessary microenvironment for cellular repair after experiencing damage from injury or disease conditions, likely affecting pain perception as well

Yes, it may cause constipation as one of its side effects